BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19041964)

  • 1. Staging of upper limb lymphedema from routine lymphoscintigraphic examinations.
    Gebouský P; Kárný M; Krízová H; Wald M
    Comput Biol Med; 2009 Jan; 39(1):1-7. PubMed ID: 19041964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphedema secondary to breast cancer treatment: possibility of diagnostic and therapeutic prevention].
    Campisi C; Boccardo F; Zilli A; Maccio A; Napoli F; Ferreira Azevedo W; Fulcheri E; Taddei G
    Ann Ital Chir; 2002; 73(5):493-8. PubMed ID: 12704989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity.
    Szuba A; Strauss W; Sirsikar SP; Rockson SG
    Nucl Med Commun; 2002 Dec; 23(12):1171-5. PubMed ID: 12464781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema.
    Szuba A; Shin WS; Strauss HW; Rockson S
    J Nucl Med; 2003 Jan; 44(1):43-57. PubMed ID: 12515876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoscintigraphic analysis in chromoblastomycosis.
    Ogawa MM; Alchorne MM; Barbieri A; Castiglioni ML; Penna AP; Tomimori-Yamashita J
    Int J Dermatol; 2003 Aug; 42(8):622-5. PubMed ID: 12890106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of SPECT/CT imaging to the lymphoscintigraphic investigations of the lower limb lymphedema.
    Baulieu F; Bourgeois P; Maruani A; Belgrado JP; Tauveron V; Lorette G; Vaillant L
    Lymphology; 2013 Sep; 46(3):106-19. PubMed ID: 24645534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The added value of SPECT/CT lymphoscintigraphy in the initial assessment of secondary extremity lymphedema patients.
    Yoon HJ; Woo KJ; Kim JY; Kang SY; Moon BS; Kim BS
    Sci Rep; 2023 Nov; 13(1):19494. PubMed ID: 37945581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphoscintigraphic aspects of the effects of manual lymphatic drainage].
    Ferrandez JC; Laroche JP; Serin D; Felix-Faure C; Vinot JM
    J Mal Vasc; 1996; 21(5):283-9. PubMed ID: 9026543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoscintigraphic abnormalities in the contralateral lower limbs of patients with unilateral lymphedema.
    de Almeida CA; Lins EM; Brandão SCS; Ferraz ÁAB; Pinto FCM; de Barros Marques SR
    J Vasc Surg Venous Lymphat Disord; 2017 May; 5(3):363-369. PubMed ID: 28411704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Upper Limb Lymphatic System: A Prospective Lymphoscintigraphic Study in Melanoma Patients and Healthy Controls.
    Rossi M; Grassi R; Costa R; Di Rosa L; D'Arpa S; Moschella F; Cordova A
    Plast Reconstr Surg; 2016 Dec; 138(6):1321-1331. PubMed ID: 27537229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation by lymphoscintigraphy of the effect of a micronized flavonoid fraction (Daflon 500 mg) in the treatment of upper limb lymphedema.
    Pecking AP
    Int Angiol; 1995 Sep; 14(3 Suppl 1):39-43. PubMed ID: 8919264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoscintigraphic evaluation in patients after erysipelas.
    de Godoy JM; de Godoy MF; Valente A; Camacho EL; Paiva EV
    Lymphology; 2000 Dec; 33(4):177-80. PubMed ID: 11191659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Types of lymphoscintigraphy and indications for lymphaticovenous anastomosis.
    Maegawa J; Mikami T; Yamamoto Y; Satake T; Kobayashi S
    Microsurgery; 2010 Sep; 30(6):437-42. PubMed ID: 20878726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of lymphoscintigraphy in patients with gynecological cancer-related lymphedema.
    Yoo J; Choi JY; Hwang JH; Kim DI; Kim YW; Choe YS; Lee KH; Kim BT
    J Surg Oncol; 2014 Jun; 109(8):760-3. PubMed ID: 24609802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for Study of the Deep Subfascial Lymphatic Vessels During Lymphoscintigraphy for the Diagnosis of Peripheral Lymphedema.
    Campisi CC; Ryan M; Villa G; Di Summa P; Cherubino M; Boccardo F; Campisi C
    Clin Nucl Med; 2019 Feb; 44(2):91-98. PubMed ID: 30516673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indocyanine Green Lymphography, Lymphoscintigraphy, and Genetic Analysis in Nonsyndromic Primary Lymphedema: The Distal Dermal Backflow Grading System and the Print Sign.
    Mangialardi ML; Lorenzano V; Pagliara D; Visconti G; Gentileschi S; Salgarello M
    J Reconstr Microsurg; 2020 Mar; 36(3):157-164. PubMed ID: 31652480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between Lymphedema Disease Severity and Lymphoscintigraphic Findings: A Clinical-Radiologic Study.
    Maclellan RA; Zurakowski D; Voss S; Greene AK
    J Am Coll Surg; 2017 Sep; 225(3):366-370. PubMed ID: 28669886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoscintigraphy in angiomyomatous hamartomas and primary lower limb lymphedema.
    Bourgeois P; Dargent JL; Larsimont D; Munck D; Sales F; Boels M; De Valck C
    Clin Nucl Med; 2009 Jul; 34(7):405-9. PubMed ID: 19542941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients.
    Weissleder H; Weissleder R
    Radiology; 1988 Jun; 167(3):729-35. PubMed ID: 3363131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphedemas of the lower limbs: a lymphoscintigraphic study].
    Cestari SC; Petri V; Castiglioni ML; Lederman H
    Rev Assoc Med Bras (1992); 1994; 40(2):93-100. PubMed ID: 7820157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.